US Women & PrEP Working Group

The US Women and PrEP Working Group is a coalition of women from leading AIDS and women’s health organizations. The coalition advocates for a coordinated national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection.

The Working Group also organizes periodic community education and outreach opportunities, including webinars and meetings at conferences, highlighting issues relevant to women and PrEP in the US.


Your gift will help ICW continue its important work supporting and empowering women and girls living with HIV around the world.